#8 - Genzyme
500 Kendall St.
Cambridge, MA 02142
Tel: (617) 252-7500
Fax: (617) 252-7600
www.genzyme.com
| Headcount | 9,000+ | |
| Year Established | 1981 | |
| Biopharma Revenues | $2,278 | +20% |
| Total Revenues | $3,187 | +17% |
| Net Loss | $17 | n/a |
| R&D Budget | $650 | +29% |
| Top Selling Drugs |
|||
| Drug | Indication | Sales | (+/-%) |
| cerezyme | Gaucher disease | $1,007 | +8% |
| renagel | hemodialysis | $515 | +24% |
| fabrazyme | Fabry disease | $359 | +18% |
| thymoglobulin/lymphoglobulin | transplantation | $150 | +17% |
| thyrogen | hyperthyroidism | $94 | +21% |
| hectorol | renal disease | $93 | +166% |
Account for 97% of total biopharma sales, down from 100% in 2005.
For the full profile, including pipeline and patent information, download the PDF.
